1. Home
  2. EIC vs GNFT Comparison

EIC vs GNFT Comparison

Compare EIC & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIC
  • GNFT
  • Stock Information
  • Founded
  • EIC N/A
  • GNFT 1999
  • Country
  • EIC United States
  • GNFT France
  • Employees
  • EIC N/A
  • GNFT N/A
  • Industry
  • EIC Finance/Investors Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EIC Finance
  • GNFT Health Care
  • Exchange
  • EIC Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • EIC 242.6M
  • GNFT 249.0M
  • IPO Year
  • EIC 2019
  • GNFT 2019
  • Fundamental
  • Price
  • EIC $16.28
  • GNFT $6.06
  • Analyst Decision
  • EIC
  • GNFT Strong Buy
  • Analyst Count
  • EIC 0
  • GNFT 1
  • Target Price
  • EIC N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • EIC 116.0K
  • GNFT 26.3K
  • Earning Date
  • EIC 11-14-2023
  • GNFT 09-19-2024
  • Dividend Yield
  • EIC 13.63%
  • GNFT N/A
  • EPS Growth
  • EIC N/A
  • GNFT N/A
  • EPS
  • EIC 0.80
  • GNFT 0.47
  • Revenue
  • EIC N/A
  • GNFT $86,225,222.00
  • Revenue This Year
  • EIC N/A
  • GNFT $155.44
  • Revenue Next Year
  • EIC N/A
  • GNFT N/A
  • P/E Ratio
  • EIC $20.31
  • GNFT $12.34
  • Revenue Growth
  • EIC N/A
  • GNFT 175.45
  • 52 Week Low
  • EIC $13.00
  • GNFT $2.97
  • 52 Week High
  • EIC $16.48
  • GNFT $6.08
  • Technical
  • Relative Strength Index (RSI)
  • EIC 60.14
  • GNFT 69.91
  • Support Level
  • EIC $16.35
  • GNFT $5.41
  • Resistance Level
  • EIC $16.58
  • GNFT $5.84
  • Average True Range (ATR)
  • EIC 0.16
  • GNFT 0.30
  • MACD
  • EIC 0.04
  • GNFT 0.04
  • Stochastic Oscillator
  • EIC 58.33
  • GNFT 98.03

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: